Research Papers:
Effects of Abies sibirica terpenes on cancer- and aging-associated pathways in human cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2582 views | HTML 4059 views | ?
Abstract
Anna Kudryavtseva1,2,*, George Krasnov1,*, Anastasiya Lipatova1, Boris Alekseev2, Faniya Maganova3, Mikhail Shaposhnikov4, Maria Fedorova1, Anastasiya Snezhkina1, Alexey Moskalev1,4,5
1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia
2National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
3Initium-Pharm, LTD, Moscow, 142000, Russia
4Institute of Biology of Komi Science Center of Ural Branch of RAS, Syktyvkar, 167982, Russia
5Moscow Institute of Physics and Technology, Dolgoprudny, 141700, Russia
*These authors have contributed equally to this work
Correspondence to:
Alexey Moskalev, email: [email protected]
Keywords: Abies sibirica, plant extract, terpenoids, anti-aging effects, anti-cancer effects
Received: August 12, 2016 Accepted: October 19, 2016 Published: November 19, 2016
ABSTRACT
A large number of terpenoids exhibit potential geroprotector and anti-cancer properties. Here, we studied whole transcriptomic effects of Abisil, the extract of fir (Abies sibirica) terpenes, on normal and cancer cell lines. We used early passaged and senescent none-immortalized fibroblasts as cellular aging models. It was revealed that in normal fibroblasts, terpenes induced genes of stress response, apoptosis regulation and tissue regeneration. The restoration of the expression level of some prolongevity genes after fir extract treatment was shown in old cells. In Caco-2 and AsPC-1 cancer cell lines, Abisil induced expression of both onco-suppressors (members of GADD45, DUSP, and DDIT gene families), and proto-oncogenes (c-Myc, c-Jun, EGR and others). Thus, the study demonstrates the potential anti-aging and anti-cancer effects of Abisil on senescent and cancer cell lines.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13467